Non-alcoholic fatty liver disease: An emerging liver disease in Taiwan

被引：30

作者：

Hsu, Ching-Sheng ^{[1
,2
,3
,4
]}

Kao, Jia-Horng ^{[1
,4
,5
,6
,7
]}

机构：

[1] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei 10002, Taiwan

[2] Buddhist Tzu Chi Gen Hosp, Dept Internal Med, Div Gastroenterol, Taipei Branch, Taipei, Taiwan

[3] Tzu Chi Univ, Sch Med, Hualien, Taiwan

[4] Natl Taiwan Univ Hosp, Taipei, Taiwan

[5] Natl Taiwan Univ, Coll Med, Dept Med Res, Taipei 10002, Taiwan

[6] Natl Taiwan Univ, Coll Med, Hepatitis Res Ctr, Taipei 10002, Taiwan

[7] Natl Taiwan Univ, Coll Med, Dept Internal Med, Taipei 10002, Taiwan

来源：

JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION | 2012年 / 111卷 / 10期

关键词：

fatty liver; hepatitis B virus; hepatitis C virus; metabolic syndrome; NASH; Taiwan; ASIA-PACIFIC REGION; CHRONIC HEPATITIS-C; INSULIN-RESISTANCE; METABOLIC SYNDROME; RISK-FACTORS; HEPATOCELLULAR-CARCINOMA; LIPID-PEROXIDATION; ADULT-POPULATION; DIAGNOSTIC-VALUE; CHINESE PATIENTS;

D O I：

10.1016/j.jfma.2012.07.002

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Non-alcoholic fatty liver disease (NAFLD) is the most common liver disorder in Western countries, and has become increasingly recognized as a public health problem in Taiwan. Patients with non-alcoholic steatohepatitis, a more severe form of NAFLD, may progress to cirrhosis and its related complications, including hepatocellular carcinoma. Since NAFLD is highly linked to metabolic syndrome, such patients may have increased risks of complications related to both liver disease and metabolic syndrome. Therefore, if we fail to cope with this growing health problem, NAFLD may gradually replace viral hepatitis as the major etiology of liver disease in Taiwan. Copyright (C) 2012, Elsevier Taiwan LLC & Formosan Medical Association. All rights reserved.

引用

页码：527 / 535

页数：9

共 50 条

[21] Non-alcoholic fatty liver disease
Farrell, Geoffrey C.
Wardell, Rebecca
Teoh, Narci
Chitturi, Shiv
[J]. INTERNAL MEDICINE JOURNAL, 2019, 49 (05) : 681 - 683
[22] Non-alcoholic fatty liver disease
Sattar, Naveed
Forrest, Ewan
Preiss, David
[J]. BMJ-BRITISH MEDICAL JOURNAL, 2014, 349
[23] Non-alcoholic fatty liver disease
Li, Wenhao
Alazawi, William
[J]. CLINICAL MEDICINE, 2020, 20 (05) : 509 - 512
[24] Non-Alcoholic Fatty Liver Disease
Engin, Atilla
[J]. OBESITY AND LIPOTOXICITY, 2017, 960 : 443 - 467
[25] Non-alcoholic fatty liver disease
Brent A. Neuschwander-Tetri
[J]. BMC Medicine, 15
[26] Non-alcoholic fatty liver disease
Alba, LM
Lindor, K
[J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2003, 17 (08) : 977 - 986
[27] Extracellular Vesicles in Non-alcoholic Fatty Liver Disease and Alcoholic Liver Disease
Wu, Dongqing
Zhu, Huaqing
Wang, Hua
[J]. FRONTIERS IN PHYSIOLOGY, 2021, 12
[28] Parental non-alcoholic fatty liver disease increases risk of non-alcoholic fatty liver disease in offspring
Long, Michelle T.
Gurary, Ellen B.
Massaro, Joseph M.
Ma, Jiantao
Hoffmann, Udo
Chung, Raymond T.
Benjamin, Emelia J.
Loomba, Rohit
[J]. LIVER INTERNATIONAL, 2019, 39 (04) : 740 - 747
[29] Non-alcoholic fatty liver disease and liver secretome
Khan, Muhammad Sohaib
Lee, Choongho
Kim, Sang Geon
[J]. ARCHIVES OF PHARMACAL RESEARCH, 2022, 45 (12) : 938 - 963
[30] Non-alcoholic fatty liver disease and liver transplantation
Khan, Reenam S.
Newsome, Philip N.
[J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 2016, 65 (08): : 1208 - 1223

← 1 2 3 4 5 →